Healthcare
Tuesday, April 5, 2016
BRIEF-Sareum Holdings says CHK1 approved for clinical trials
* CHK1 inhibitor cct245737 approved for clinical trials in cancer patients
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment